Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device

Teal Health raised $22 million in Series A funding for an at-home HPV cervical cancer screening device. The round was led by .406 Ventures with participation from Emerson Collective, Forerunner, Serena Ventures, and MPower Partners. The device addresses a gap in accessible cervical cancer screening by enabling testing outside traditional clinical settings.